Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)
| Autor: | Philippe Bougnoux, C. F. Slabber, G. Villanova, Kadri Altundag, Rustem Khasanov, Agustí Barnadas, Patricia Dodyk, Saverio Cinieri, Marcus Schmidt, Ann Vandebroek, Daniel Rauch, Dar-Ren Chen, Nicole Tubiana-Mathieu, Michiel Botha, Maria Jose Godes, Ugur Coskun, J. Cárdenas, Arlene Chan, Javier Castellanos Diez, Silvia Lazzarelli |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty business.industry Standard treatment Combination chemotherapy medicine.disease Vinorelbine Metastatic breast cancer Gemcitabine Capecitabine chemistry.chemical_compound Docetaxel Paclitaxel chemistry Internal medicine medicine bacteria skin and connective tissue diseases business medicine.drug |
| Popis: | 1044 Background: Combination chemotherapy (CT) is among the standard treatment options in metastatic breast cancer (MBC), especially in patients (pts) with visceral metastases or need of rapid symp... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|